Search clinical trials for: YM598

Total 2 results

Astellas Pharma Inc
Astellas Pharma US, Inc.

Terminated

YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

Prostate Cancer

Belgium, Czech Republic, France, Germany, Poland, Spain, United Kingdom
Astellas Pharma Inc
Astellas Pharma US, Inc.

Terminated

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Prostatic Neoplasms | Hormone-Refractory Prostate Cancer

United States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain

3

Subscribe